Revenue (Quarterly) Chart

View Revenue (Quarterly) for WORXD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 0.706M
March 31, 2026 0.7449M
December 31, 2025 0.7689M
September 30, 2025 0.7058M
June 30, 2025 0.6826M
March 31, 2025 0.7203M
December 31, 2024 0.6757M
September 30, 2024 0.7597M
June 30, 2024 0.742M
March 31, 2024 0.8121M
December 31, 2023 0.9103M
September 30, 2023 0.9061M
June 30, 2023 0.9911M
March 31, 2023 0.9974M
December 31, 2022 1.028M
September 30, 2022 0.9869M
June 30, 2022 0.9924M
March 31, 2022 1.031M
December 31, 2021 1.250M
September 30, 2021 1.138M
June 30, 2021 1.096M
March 31, 2021 1.148M
December 31, 2020 1.473M
Date Value
September 30, 2020 1.171M
June 30, 2020 1.445M
March 31, 2020 1.124M
December 31, 2019 1.253M
September 30, 2019 1.682M
June 30, 2019 1.365M
March 31, 2019 1.248M
December 31, 2018 0.848M
September 30, 2018 0.9758M
June 30, 2018 0.8121M
March 31, 2018 0.7861M
December 31, 2017 0.0602M
September 30, 2017 0.0403M
June 30, 2017 0.3586M
March 31, 2017 0.7548M
December 31, 2016 0.5914M
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 0.00
Health Catalyst, Inc. 70.49M
GoodRx Holdings, Inc. 200.41M
Claritev Corp. 257.48M
iSpecimen, Inc. 0.1519M